WEBINAR: UPDATE ON EXPRESS SCRIPTS

Contract Pharmacies and Covered Entities are facing yet another round of restrictions and changes regarding the submission of 340B-eligible claims. Shortly after various manufacturer notices this past year, Express Scripts’ (ESI) updates, which went into effect Monday, March 1st, will govern what pharmacies in the pharmacy benefit managers network must do in order to identify a previously submitted claim as 340-eligible.

With these updates, the contract pharmacy will also be required to resubmit a claim to Express Scripts electronically, even after the Covered Entity has previously submitted the eligible claim. Covered Entities worry that these contract pharmacies are unaware of the update.

These 340B entities run the risk of being unable to access 340B pricing and drugs under contract pharmacy replenishment inventory systems and could potentially be billed a wholesale acquisition cost if they can’t or won’t comply with Express Scripts’ new requirements.

340Basics is dedicated to not only providing cutting-edge software but delivering answers and information to the 340B community. We have partnered with Powers Law Firm to deliver a webinar focusing on Express Scripts updates and new 340B requirements.

Powers Law Firm is a leading Washington, DC based healthcare, education and government relations law firm with a nationwide practice. Peggy Tighe, Principal, will be leading the discussion and will be available to answer questions.

For more information about the recent notice of 340B claim requirements from Express Scripts, watch a recording of our recent webinar with Powers Law Firm. This in-depth webinar focuses on the overview of the notice, the concerns with the notice, and the actions that are being taken. View Webinar Recording Now.

STAY UP TO DATE

Sign up to receive updates and notifications regarding recent

340Basics' blog posts.

SIGN UP

ARE YOU HRSA AUDIT READY?

SIGN ME UP FOR UPDATES

Archives

A Solution For The Times

Now is the time to realize the importance of having a flourishing in-house pharmacy. Whether you’re building and credentialing a pharmacy from scratch or revamping an existing operation, shielding your program from manufacturer restrictions is key. At Apovia, we’re committed to safeguarding our CE partners’ resources so they can continue providing quality healthcare to at-risk populations.

Contact our team today.